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MEASUREMENT OF CUTANEOUS ANTI-INFLAMMATORY ACTIVITY
OF ACTH AND CORTICOSTEROIDS IN MAN*
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Immense quantities of systemic corticosteroids
are prescribed each year for inflammatory condi-
tions. The recent plethora of newer analogues has
obscured the fact that present guides to selection
of drug or dosage are inadequate. Animal studies,
utilizing the granuloma pouch (1) or thymus
involution (2), do not regularly carry over to
man. Determinations of eosinopenic or gluco-
corticoid activity are at best indirect measures;
and clinical studies are time consuming and
difficult to interpret.
The present study deals with a method for
evaluating systemically administered antiphlo-
gistic agents in man. We explored the questions
of how and when to give the drug, and in addi-
tion, compared hydrocortisone and ACTH for
efficacy.
METHOI)
After some preliminary study of allergens and
irritants, eroton oil was chosen as the phlogistic
agent.
For testing, 0.25 ml. aliquots of 1, 10, and 25 per
cent acetone solutions of croton oil were dropped
on the skin of the back within the area of a ring
2.9 cm. in diameter. The acetone was evaporated
under a stream of air leaving the oily substance
on the skin surface. These test areas were covered
with a plastic band-aid. In 24 hours the sites were
observed and graded on an arbitrary scale from
1 toG:
1—negative.
2—occasional, scattered, tiny pustules or cry-
thematous papules.
3—small pustules covering less than half the
test site.
4—small to moderately-sized pustules involving
mnre than half the test site.
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5—moderate pustulation scattered over the
entire test site.
6—large pustules densely accumulated.
To limit subjective variation, two observers
graded the reactions independently.
The subjects, healthy white males 25 to 50 years
old, were tested each week at new sites on the
back. Care was taken not to apply eroton oil to
recently irritated areas.
Many anti-inflammatory drugs were used over a
two and one-half year period to perfect the test
method. The drugs were administered only during
the 24 hour testing periods and were prescribed
randomly in a way unknown to the observers;
controls were performed periodically. The results
were recorded as degree of inhibition, i.e., values
of control patch test reactions minus values ob-
tained during therapy.
The effects of varying the route of administra-
tion were evaluated by comparing the action of
hydroeortisone* and methylprednisolonet given
by mouth, and also by intravenous and intramus-
cular routes. Similarly four different time sched-
ules were studied to determine the best method of
dividing a particular daily dose.
Hydroeortisone (F) and ACTH-gel (ACTH)
were evaluated in 12 select subjects by giving the
drugs repeatedly in varying doses during eroton
oil exposure. Twenty-four hour urine samples
were collected during ACTH therapy in 7 sub-
jects, and 17-hydroxyeortieoids determined ac-
cording to a modified Reddy extraction (3) and
Porter-Silber ehromagen estimation (4, 5). The
result was converted by formula (6) to milligrams
of endogenously secreted compound F per twenty-
four hours.
RESULTS
1. Control studies. Croton oil caused a rapidly
evolving, easily graded, follicular pustular erup-
tion that responded measurably to anti-inflam-
matory medication (Fig. 1). It caused consistent
responses (Table 1). No sensitization occurred.
Rarely, a subject reacted violently to all eroton
* Supplied by Dr. Nicholas Capeei of MerckSharp & Dohme.
t Medrol® and Solu-Medrol® supplied by Dr.
Porter F. Crawford of The Upjohn Company.
t H. P. Aethar Gel® supplied by Dr. J. A. Hu-
bata of Armour Pharmaceutical Company.
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oil dilutions. At these times eortieosteroids had
no inhibitory effect. With a short rest the skin
reactivity returned to normal; eoaditioned
irritability, as we know it (7, 8), was not seen.
No one was removed from the test for persistent
hyperirritability of their skin.
2. C'orticosteroid responses. The well known
individual variation in response to eortieosteroids
was clearly demonstrated. A few subjects evinced
nearly complete pustule inhibition while taking
less than 200 mgs. a day of hydrocortisone;
others responded poorly to 400 mgs. a day. In
addition, the same dose of a drug produced some
variation in anti-iaflammatory response when
given from week to week in the same subject. In
comparative evaluations the results of these
repeated studies were averaged.
A curious phenomenon was observed in new
subjects. Many showed a greater degree of
pustule inhibition on low doses of eortieosteroids
than did veteran subjects (Fig. 2). The period
of "steroid-sensitivity" lasted about six to
twelve weeks. During this time comparative
studies with different antiphlogistie drugs gave
valid results, but after a while, larger doses of
eortieosteroids were required to achieve corn-
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FIG. 1. Reactions to 1% (top), 10%, and 25% (lower) dilntions of eroton oil. Control on the right
would be graded 3.5 (top), 4.5 (mid), and 5.0 (lower). On left, response in the same subject to 80 units
ACTH-gel intramuscularly b.i.d., 1 (top), 1 (mid), and 1.5 (lower).
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TABLE I
Variation in response to dilutions of
croton oil over a two year period
Date
Croton Oil
Subjecl A Subjeci B
1% 10% 25% 1% 10% 25%
July, 1958 4.0 5.0 5.5 2.0 3.0 4.0
January, 1959.. 3.5 4.5 5.0 2.0 3.5 4.0
Novembar,
1959 4.0 4.5 5.5 2.0 3.0 3.5
February,1960. 4.0 4.5 5.0 3.0 3.5 4.0
Juae, 1960 3.5 4.0 5.0 2.0 4.0 4.0
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Fsa. 2. Variation in anti-inflammatory effect
of hydrocortisone in the same subject with re-
peated testing. While control values hardly
changed, the subject became resistant to the ef-
fect of hydrocortisone after 3 months.
parable anti-inflammatory results. With repeated
testing, a second plateau of reactivity was reached
at which large doses of the drugs produced
consistent anti-inflammatory effects. It should
be emphasized that control responses to croton
oil were not altered during this transition.
3. Ronte of administration. We discovered no
advantage of intramuscular over oral therapy.
Comparable doses of intramuscular hydro-
cortisone phosphate and oral hydrocortisone
behaved exactly alike in preventing pustule
formation. Similarly methylprednisolone sodium
succinate intramuscularly acted precisely like
methyiprednisolone by mouth. Intravenously
methylprednisolone sodium succinate proved
slightly more potent than comparable oral
preparations so long as a divided dose was
given.
4. Dosage schedules. Pustule inhibition was
about the same whether three or four divided
doses were given. A single large dose, or even two,
had a lessened effect. For maximum antiphlogistic
activity the drugs had to be administered
throughout the entire test period. Prc-treatment
with corticosteroids did not alter the outcome of
the test, but if one of the divided doses (especially
the early morning dose) was omitted, the anti-
inflammatory result was compromised.
5. Ilydrocortisone versvs £4CTH. The average
inhibitory advantage of one dose of either drug
over another dose is recorded in descending order
of potency in Table IT. A more assimilable
presentation of the data is shown in Fig. 3. The
findings demonstrated that moderate doses of
ACTH produced a more salutary effect than
large doses of hydrocortisone. ACTH-gel, 80
units intramuscularly twice a day, produced an
optimal anti-inflammatory response in nearly
every subject. It definitely eclipsed the inhibitory
effect of 400 mg. of hydrocortisone; in a few
subjects as much as 600 mg. a day of hydrocorti-
sone were required to produce maximal inhibi-
tion. A single injection of 80 units of ACTH-gcl
gave about the same results as 200 mg. of oral
hydrocortisonc. The urinary studies (Table
III, Fig. 4) re-enforced the view that ACTII
acts more efficiently than oral hydrocortisone in
causing an anti-inflammatory effect. On the
average, 82 mg. of endogenous compound F was
as potent as 200 mg. of oral hydrocortisone. At
maximum inhibition the cndogenous secretion
was more than two and one-fourth times as effec-
tive as the oral drug. In any given subject opti-
mum adrenal secretion w-as well correlated with
maximum anti-inflammatory effect.
DI5CU55ION
We have designed a method for directly
measuring anti-inflammatory activity in man.
In structure it falls between standard laboratory
procedures and strictly clinical appraisal. The
exasperating variables that plague clinical trials
have been removed or controlled. Instead of the
vagaries of an unpredictable disease, we deal
with controlled inflammation. Witkowski and
Kligman (9) found croton oil most useful for
producing standard skin irritation. It causes a
distinctive reaction which is reproducible and
easily graded. In our experience simple erythro-
genie responses tend to be quite variable and
CONICOL
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TABLE II
Mean differences of degrees of inhibition1 for 1, 10, l5 per cent levels of croton oilI
1 Row minus column.
2 Data analysed by t-method for determining
* Significant at the 5 per cent level.
Significant at the 1 per cent level.
TABLE III
Twenty-four hour secretion of compound F in
milligrams following adrenal stimulation with
varying doses of intramuscular ACTH-gel in nor-
mal subjects. The values are approximations de-
termined by conversion of 17-hydroxycorticoid
levels measured in urine (6). Notice the remarkable
degree of variation.
Subject 80 units 1X 40 units bid. 80 units bid.
1 35 77 137
2 113 — 167
3 176 192 273
4 85 110 201
5 64 106 123
6 90 92 187
7 — 123 178
Drug Dosage Per Cent ACTHCroton Oil 80 bid.
F
400 mg.
ACTH
40 bid.
F
280 mg.
ACTH
80 1X
F
200 mg.
ACTH
80 units
b .i .d
F
400 mg
per day
ACTH
40 units
b .i .d
F
280 mg
per day
ACTH
80 units
lx
F
200 mg
per day
10
25
10
25
10
25
1
10
25
10
25
10
25
0.130
0.425
0.845*
0.205
1 .027**
1 .427**
0.045
0.605
0.525
0.975*
1 .865**
2.105**
0.917*
1.544**
1.289**
0.727
0.895**
0.623*
1.167
2.056**
2.000*
1.167
1.639**
1. 292*
1. 286*
1.270*
1.000*
0.750
0.428
0.236
0.083
0.042
1.167*
1 .687**
2.161**
1.022*
1 .562*
1 .389**
1.175*
1.046k
0 .875**
0.250
0.671
0.322
0.313
differences of paired observations.
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FIG. 3. Average response to various doses of
ACTH or hydrocortisone in 12 subjects. Degree
of inhibition is determined by subtracting treat-
ment values from control values. Notice that 80
units of ACTH-gel bid, caused essentially com-
plete pustule inhibition at the 1 and 10 per cent
levels of croton oil but fell off in effect at the 25%
per cent level. It was clearly more potent than
400 mg. of hydrocortisone given throughout a 24
hour testing period.
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defy consistent interpretation. Other test methods
using an erythematous end point (10-12) have
failed in our hands. Perhaps the erythema pro-
duced by tetrahydrofurfuryl alcohol (13, 14) will
prove reliable. Individual variation in response
to eortieosteroids has been allowed for by re-
peatedly testing subjects whose response is known
and predictable.
Our findings have practical implications. Within
the limits of the test method we affirm that divided
dosage schedules are important. One or two large
doses lack the effect of three or four smaller
ones. Punctilious attention to the details of
scheduling, however, is not required. Intramus-
cular injections of eortieosteroids offer no ad-
vantage over oral therapy. Intravenous corti-
eosteroids, on the other hand, are slightly more
effective than oral or intramuscularly admin-
istered drugs. There may be some merit to using
intravenous preparations, but Goldberg's en-
thusiasm for intravenous methylprednisolone
(15) seems exaggerated.
The anti-inflammatory potency of ACTH is
proportional to its steroidogenic effect. The
question of extra-adrenal activity of ACTH
(9, 16—18) was not resolved because complete
pustule inhibition appeared at doses of ACTH
which evoked maximal secretion of compound
F (between 150—300 mg/24 hours) (6). Orally
administered compound F had less than half
the activity of the endogenously secreted hor-
mone. A clinical study of steroid therapy in
pemphigus led Rezniek et al (19) to much the
same conclusion; they found 240 units of ACTH-
gel equivalent to 600 mg. cortisone in controlling
the disease. Stoughton's experience in the treat-
ment of pemphigus was the same (20). These
findings underscore the efficiency of ACTH as
an antiphlogistie agent. In any therapeutic
situation the clinician must decide whether to
sacrifice efficiency and economy for convenience
(21). Too often the choice is based on whimsy.
In a disease like pemphigus where large doses of
eortieosteroids are required, the question be-
comes imminently practical.
SUMMARY
A method is described for evaluating system-
ically administered anti-inflammatory drugs in
man. Croton oil was chosen as the phlogistic
agent because it produces a distinctive, easily
graded reaction which is reproducible and is
measurably altered by antiphlogistie therapy.
Using this method we affirmed that divided doses
of eortieosteroids are important, but route of
administration matters little. Furthermore, it
was found that moderate doses of ACTH pro-
duce a greater anti-inflammatory effect than
large (loses of hydroeortisone. The practical
implications of these findings are discussed.
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Fio. 4. Average comparative anti-inflammatory
responses of endogenous compound F caused by
ACTH stimulation and exogenous compound F
given by mouth in seven subjects. A small quan-
tity of the endogenous compound goes a long
way.
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DISCUSSION
DR. WALTER F. LEVEE (Boston, Mass.):
Dr. Epstein's paper has shown that SO units of
ACTH are more effective than 400 mg. of hydro-
cortisone in suppressing the skin irritation in-
duced by eroton oil. It seems to me entirely
unjustified to conclude from this observation
that ACTH has greater efficiency than cortisone.
It was a rather arbitrary decision of the authors
to compare SO units of one drug with 400 mg. of
the other. It is quite likely had the authors com-
pared SO units of ACTH with 800 mg. of cortisone
they would have found cortisone more effective
than ACTH.
DR. STEPHEN ROTEMAN (Chicago, Ill.): I am
afraid Dr. Lever missed the point. rhe authors
have measured the adrenal stimulation by ACTH
through estimation of the excretion of 11-
hydroxy-17-Kctosteroids in the urine. Although
the amount of these metabolites was less than
the administered hydrocortisonc in comparable
experiments, the anti-inflammatory effect of
ACTH was greater.
I wonder if the data given here should be
represented in the form of a continuous curve or
whether to show the single data in columnar
form would not give a more accurate picture.
DR. ARTHUR C. CURTIS (Ann Arbor, Michi-
gan): Perhaps the more efficient inhibition of
inflammation by ACTH noted by the authors
was due to the anti-inflammatory effect of both
the ACTH and adrenal steroidogenesis produced
by it. When corticosteroids alone are used adrenal
steroidogcnesis is depressed so less summation
effect occurs.
DR. WILLIAM L. EPSTEIN (in closing): I think
Dr. Rothman has answered Dr. Lever's question.
I agree the term "efficiency" may be misleading,
but if you think in terms of the amount of con'-
pound F required to cause pustule inhibition, it
becomes clear that ACTH is more efficient than
exogenously administered compound F. At
maximum adrenal stimulation it causes no more
than 200—300 mg. of compound F to be secreted
in 24 hours. This amount of endogenous F has a
greater inhibitory effect than 400 mg. of exog-
enous F.
The curves which I presented, Dr. Hothman,
are set to scale. They communicate my points
directly and simply.
I agree with Doctor Curtis that the responsive-
ness of the adrenal cortex to ACTH partially
determines the inhibitory effect we see. My data
demonstrate this fact very nicely, hilt aside
from that there are many other variables to be
taken into account. The technic I propose allows
for better control of these factors than that
observed in usual clinical trials.
